Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat …

SAN MATEO, Calif., Aug. 19, 2024 /PRNewswire/ — Talphera, Inc. (Nasdaq: TLPH), (“Talphera”), a specialty pharmaceutical company focused on the …

Continue

Do you trust this headline?

Based on recent headline ratings, 83% of this readership currently trusts the local media, which has an average score of 80% regionally and is currently trending positivepositive.

83%

Media Trust Score83%

Read All

In

News